Pfizer drug effective in patients with rare lung cancer -study
September 27, 2014 at 06:45 AM EDT
Sept 27 (Reuters) - Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.